Spin-off news

Here you can find news from MPG spin-off companies.

Alnylam Initiates ILLUMINATE-B Phase 3 Pediatric Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1

Evotec and venture capital consortium form Breakpoint Therapeutics GmbH

Evotec completes acquisition of Just Biotherapeutics

MorphoSys's Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019

  • Page 3 of 3